AstraZeneca records $4 billion revenue from vaccine sales as it takes profit for the first time ever from the jabs
AstraZeneca, one of the first companies which successfully produced Covid-19 vaccines recorded a full year revenue of $37.4 in 2021 where the company started to make profit from the vaccine for the first time ever. The 2021 revenue is an increase of 38% from the previous year and the revenue from the vaccine sales alone … Read more